Patrick Lilly, Chief Executive Officer, Liquid Biosciences. 25 years driving innovation and growth in biotech, software, high-performance computing, and wireless. Member of FDA’s MDepiNet Blockchain and AI Task Force; Co-Chair, AI Subcommittee. Contracted with nine of the top ten pharmaceutical companies and three world-renowned research institutions. Co-founded four technology start-ups and five life sciences companies and discovered hundreds of novel biomarkers for 28 diseases. Inventor of 75 technology patents and trade secrets in bioinformatics, tissue sample quality control, high-performance algorithms, security, and wireless. Guest lectured at Cal Tech, MIT, Stanford, UC Berkeley, USC, and others. Board Member of Mamogen, HepGene and LiquidLung. Patrick received his B.A. and MBA from University of California, Irvine.